Astec LifeSciences Limited (NSE:ASTEC)

Astec LifeSciences Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	-	5.75	4.72	4.73	5.55	3.39
Cash & Short-Term Investments	5.75	5.75	4.72	4.73	5.55	3.39
Cash Growth	22.04%	22.04%	-0.40%	-14.63%	63.67%	9.96%
Accounts Receivable	-	1,474	1,690	1,549	2,736	1,872
Other Receivables	-	3.6	17.57	3.99	49.78	14.57
Receivables	-	1,506	1,708	1,553	2,788	1,887
Inventory	-	1,598	1,958	2,948	1,869	1,061
Prepaid Expenses	-	46.83	50.06	49.71	48.67	27.51
Other Current Assets	-	254.94	263.67	432.41	445.57	325.8
Total Current Assets	-	3,411	3,985	4,989	5,157	3,304
Property, Plant & Equipment	-	4,967	5,316	4,292	3,514	3,232
Long-Term Investments	-	0.05	0.05	0.05	0.05	0.05
Other Intangible Assets	-	234.49	194.16	159.04	113.9	51.63
Other Long-Term Assets	-	201.32	254.33	354.81	183.05	187.62
Total Assets	-	8,814	9,749	9,794	8,968	6,776
Accounts Payable	-	816.13	892.78	1,772	1,898	1,282
Accrued Expenses	-	14.56	20.08	16.51	12.55	13.18
Short-Term Debt	-	2,644	2,830	2,853	2,394	1,470
Current Portion of Long-Term Debt	-	101.76	119.37	450.39	400	1.68
Other Current Liabilities	-	81	109.79	170.46	201.32	455.83
Total Current Liabilities	-	3,657	3,972	5,262	4,906	3,223
Long-Term Debt	-	2,800	1,990	108.63	-	400
Long-Term Deferred Tax Liabilities	-	0.38	67.6	209.7	80.82	54.75
Other Long-Term Liabilities	-	3.67	4.42	4.78	4.28	5.17
Total Liabilities	-	6,464	6,054	5,599	5,001	3,683
Common Stock	-	196.11	196.09	196.06	195.98	195.88
Additional Paid-In Capital	-	613.92	610.9	607.36	603.48	598.31
Retained Earnings	-	1,536	2,882	3,386	3,162	2,293
Comprehensive Income & Other	-	1.27	3.89	3.83	3.07	4.31
Total Common Equity	2,347	2,347	3,693	4,194	3,965	3,092
Minority Interest	-	2.71	2.31	1.92	1.63	1.39
Shareholders' Equity	2,350	2,350	3,695	4,196	3,967	3,093
Total Liabilities & Equity	-	8,814	9,749	9,794	8,968	6,776
Total Debt	5,545	5,545	4,939	3,412	2,794	1,872
Net Cash (Debt)	-5,540	-5,540	-4,934	-3,407	-2,788	-1,869
Net Cash Per Share	-282.52	-282.47	-251.61	-173.77	-142.26	-95.39
Filing Date Shares Outstanding	19.6	19.61	19.61	19.61	19.6	19.59
Total Common Shares Outstanding	19.6	19.61	19.61	19.61	19.6	19.59
Working Capital	-	-245.75	13.33	-273.47	250.89	81.54
Book Value Per Share	119.70	119.70	188.32	213.90	202.32	157.84
Tangible Book Value	2,113	2,113	3,499	4,035	3,851	3,040
Tangible Book Value Per Share	107.74	107.74	178.42	205.79	196.51	155.21
Buildings	-	2,040	1,700	1,290	1,286	691.87
Machinery	-	5,032	3,815	3,201	3,107	2,104
Construction In Progress	-	1.25	1,485	1,124	137.32	1,117

Source: S&P Global Market Intelligence. Standard template. Financial Sources.